J Clin Aesthet Dermatol. 2020;13(5):29–30 by Justin W. Marson, MD and Hilary E. Baldwin, MD Dr. Marson is with the Department of Medicine at University of California Irvine in Orange,
J Clin Aesthet Dermatol. 2020;13(4):43–44 by Alexandra Wells, MD; Preeta Gupta, MD, Francis Tian, MD; Eric Adkins, MD; and Benjamin Kaffenberger, MD Drs. Wells, Tian, and Gupta are with The
Background. Dr. Frederic Mohs believed that surgery can spread a melanoma; to prevent this, he applied an inactive black paste vehicle containing the active ingredient 50% zinc chloride solution to melanomas to kill and fix (i.e., preserve) tissue; this is termed fixed-tissue surgery.
J Clin Aesthet Dermatol. 2020;13(1):41–43 by Dante Garcia, MD; Itisha S. Jefferson, BS; Pablo Ramirez, BS; Angelina Palomino, BS; William Adams, PhD; Jessica Vera, BSN; Ruby De La Torre, APN;
by Colton B. Nielson, MD; Jennifer N. Harb, MD; and Kiran Motaparthi, MD Drs. Nielson, Harb, and Motaparthi are with the Department of Dermatology at the University of Florida College
by Sophie Wang, MD; Harib Ezaldein, MD; Raghav Tripathi, MPH; Miesha Merati, DO; and Jeffrey Scott, MD Dr. Wang and Mr. Tripathi are with the Case Western Reserve University School of
J Clin Aesthet Dermatol. 2019;12(6):27–28 by Brooke Vasicek, MD; William Adams, PhD; Laryn Steadman, BFA; Jeave Reserva, MD; and James Swan, MD Drs. Vasicek, Reserva, and Swan are with the Division
by Frances Tian, MD; Katherine R. Mazurek, BA; Robert N. Malinak, BS; Steven M. Dean, DO, FACP, RPVI; and Benjamin H. Kaffenberger, MD Dr. Tian is with Ohio State University
by Gabriele F. Muti, MD, and Matteo Basso, MD Dr. Muti is with the Department of Plastic Surgery, European Dermatological Institute, in Milan, Italy. Dr. Basso is with the Studio
by Brian Tian, MBBS, Dip Derm Dr. Tian is with Singapore General Hospital, Singapore. J Clin Aesthet Dermatol. 2017;10(8):28–30 Funding: No funding was provided for this study. Disclosures: The author
by Wendy E. Roberts, MD; Lora Colvan, BS; and Vincent Gotz, MS Pharm Dr. Roberts is with Generational and Cosmetic Dermatology, Rancho Mirage, California, and Ms. Colvan and Mr. Gotz
by Brian Tian, MBBS, MRCS, Dip Derm Dr. Tian is with Singapore General Hospital in Singapore. J Clin Aesthet Dermatol. 2017;10(7):40–42 Funding: No funding was provided for this study. Disclosures:
a,bKara Capriotti, MD; a,cKevin Stewart, MD; a,cJesse Pelletier, MD; a,cJoseph Capriotti, MD aVeloce BioPharma LLC; bBryn Mawr Skin and Cancer Institute; cPlessen Ophthalmology Consultants Disclosure: Drs. Capriotti (K) and Capriotti
a)Stefano Veraldi, Md; b)Giuseppe Micali, Md; c)Enzo Berardesca, Md; b)Federica Dall’oglio, Md; c)Jo Linda Sinagra, Md; aElena Guanziroli, Md aDepartment of Pathophysiology and Transplantation, Università degli Studi di Milano, I.R.C.C.S.
Vic A. Narurkar, MD Bay Area Laser Institute, San Francisco, California Abstract Objective: To evaluate a hydrolyzed roe cream in the reduction of facial erythema following a chemical peel treatment.
aNikoo Cheraghi, MD; bAbdulhadi Jfri, MD; bRobert Bacigalupi, MD; bHooman Khorasani, MD aDepartment of Dermatology, New York Medical College, New York, New York; bDivision of Dermatologic Surgery, Department of Dermatology,
aRichard R. Winkelmann, DO; bAaron S. Farberg, MD; cNatalie Tucker, BS; dRichard White, MS; eDarrell S. Rigel, MD, MS aDepartment of Dermatology, OhioHealth, Columbus, Ohio; bClinical Research Fellow, National Society
aWilliam Kirby, DO, FAOCD; bDylan B. Alston, DO; cAlan H. Chen, MD, FACS aLaserAway and Kirby Dermatology, Hermosa Beach, California bUniversity of North Texas, Heights Dermatology and Aesthetic Center, Houston,
aEftychia Platsidaki, MD; aAnargyros Kouris, PhD; aEfthymia Agiasofitou, MD; bChristina Antoniou, MD; aGeorgios Kontochristopoulos, PhD aDepartment of Dermatology and Venereology, Andreas Sygros Skin Hospital, Athens, Greece; bDepartment of Dermatology and
Viktoryia Kazlouskaya, MD, PhD; Jacqueline M. Junkins-Hopkins, MD Ackerman Academy of Dermatopathology, New York, New York Disclosure: The authors report no relevant conflicts of interest. Abstract Red pigment tattoos are